Christoph Antz has extensive experience in managing startup and early-phase biotech companies. He recently founded Antz Consulting and currently supports governmental organizations and international research institutions in setting up and financing startup companies within the in life sciences sector.
Previously, Christoph was a Managing Director at EMBL Ventures, where he invested in 6 companies, brought 1 to IPO, and held 4 board seats.
In 1998, he co-founded Otogene (in Tübingen and Seattle), and later served as CEO at Abeta (Heidelberg), EMBL Ventures, Elara Pharmaceuticals, Grandeon, Luxendo, Acousia Therapeutics, Araxa Biosciences and Velabs Therapeutics since 2018.
Education, Personal, and Fellowship
Christoph obtained his PhD in physics/structural biology at the Max-Planck-Institute for Medical Research in Heidelberg.
A member of Class 10, Christoph served his fellowship under mentor Stefan Herr at EMBL Ventures in Heidelberg, Germany.